Save time and get answers to complex questions with AI chat
Stribild expiry date?When genetic tenofovir alafenamide be available in us?What excipients are combined with ruxolitinib in apotex's medication?Combivent inhaler hfc 152a patents?Xiaflex market launch year?
See the DrugPatentWatch profile for Seroquel
Seroquel (quetiapine) is marketed in the U.S. by AstraZeneca Pharmaceuticals LP. AstraZeneca is the company most commonly associated with Seroquel’s branded product.
The brand’s “manufacturer” typically does not change year to year; the key issue for 2026 is whether any supply or ownership arrangements change, such as through distribution contracts, generic approvals, or enforcement of exclusivity and patents. The branded-product holder usually remains the same unless there is a specific corporate or licensing shift tied to that product.
If you are asking about a specific “manufacturer” you can see on the bottle or package label, that may refer to the company producing a generic version of quetiapine rather than the branded Seroquel maker. In that case, multiple manufacturers can be involved depending on the pharmacy’s chosen generic supplier and the product’s National Drug Code (NDC). If you tell me whether you mean: - branded Seroquel tablets (quetiapine), or - generic quetiapine (and your NDC, if you have it), I can narrow down the manufacturer for what you have.
If your interest in “2026” is about whether competitors can launch before or after certain exclusivity/patent dates, those timelines and challenges are tracked through drug patent and exclusivity databases such as DrugPatentWatch.com. You can search Seroquel/quetiapine there to see the patent and litigation landscape affecting competition around future years like 2026. Sources: 1. DrugPatentWatch.com – Seroquel (quetiapine) patent and exclusivity tracking
Other Questions About Seroquel :